Home / Medical Devices / Hematology Diagnostics Market By Restorative Material Product Type (Hematology Instruments, Hematology Consumables), By End-user Segment (Diagnostic Laboratories, Hospitals & Clinics, Academic and Research Institutions) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

Hematology Diagnostics Market By Restorative Material Product Type (Hematology Instruments, Hematology Consumables), By End-user Segment (Diagnostic Laboratories, Hospitals & Clinics, Academic and Research Institutions) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

Published: Apr 2019 | Report Code: 59674-04-19

"Hematology diagnostics market to exhibit lucrative growth during the forecast period"

The global hematology diagnostics market is increasing significantly, was valued at US$ 3,167.2 Mn in 2017 and expected to reach US$ 5,288.3 Mn by 2026. Increasing blood donation procedures, rising incidences of blood disorders along with enhanced diagnostics and hematology testing technologies drives the overall hematology diagnostics market growth. New technological evolution in automated hemotology analyzers would also drive the overall market. Additionally, new standardized automated sample collection, data processing, identification & testing, and ordering of new tests among other processes will further spur revenue growth during the forecast period.

Market Synopsis

Hematology Diagnostics Market

Get a sample copy for more information

"Hematology consumables segment is expected to dominate the global market during the forecast period" 

Overall sales of hematology consumables is expanding significantly on a global scale. It is anticipated to continue its dominance during the forecast period. Rising demand for consumables along with diagnosis of blood disorders and other infections will grow prominently. Moreover, increasing volume of diagnostic tests owing to growing awareness and incidence is also driving the market growth. Wide range of reagents & kits, stains, and others in the consumables segment incorporate experts to encounter the dynamic demand. The instruments segment is further distributed into analyzers, flow cytometers, and others. Increased automation which offer noble reliability, sensitivity, specificity, along with higher safety and ease of operation are estimated to be the primary growth factors driving the hematology instruments segment globally. 

Hematology Diagnostics Market

Get a sample copy for more information

"The diagnostic laboratories segment is expected to register higher growth by the end of 2026"

Diagnostic laboratories in the end user segment are predicted to expand at a significant CAGR during the forecast period. The rising number of multispecialty diagnostic centers along with the availability of advanced hematology products are fueling the demand globally. Additionally, automation of diagnostic tools is anticipated to reduce the overall cost of blood testing. The rise in partnership among market players and diagnostic laboratories are factors that are likely to drive the market growth. The adoption of fully automated analyzers along with enhanced prognosis, infectious disease monitoring, diagnosis, and preliminary screening processes will drive the growth in the end user segment.

Hematology Diagnostics Market

Get a sample copy for more information

"Increasing demand for advanced equipment, and the presence of established players holds North America in dominant position" 

North America to contribute maximum revenue share in the global hematology diagnostics market. Factors enhancing the growth in North America include the utilization of advanced technologies for the point of care test, rising incidences for diseases such as blood cancers, acute infectious diseases, liver and spleen diseases.

Asia Pacific is expected to grow at a significant pace owing to new technology expansion and adoption of advanced diagnostic instruments. Enhanced healthcare services along with improved government initiatives will have a positive impact on the hematology diagnostics market.   

Hematology Diagnostics Market

"Dominance of multinational manufacturers with strong product portfolio in the developed regions" 

Major players in the hematology diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt. and others. Furthermore, new product launch, technology expansion to diagnostic laboratories will drive the market growth in future. Increasing prevalence of blood disorders along with other target diseases and dynamic shift from manual to automated hematology testing, and competitive benefits offered by commercial service providers in the developing nations will further assist the overall development of the market on a global scale. 

Hematology Diagnostics Market

Historical & Forecast Period 

This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026

Report Scope by Segments

 

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 Restorative Material Product Type (2016–2026; US$ Mn)
 • Hematology Instruments
   o Hematology Analyzers
   o Flow Cytometers
   o Others
 • Hematology Consumables
   o Reagents
   o Stains
   o Controls & Calibrators
   o Others

 End-user Segment (2016–2026; US$ Mn)
 • Diagnostic Laboratories
 • Hospitals & Clinics
 • Academic and Research Institutions

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (Japan, China, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East & Africa (GCC, Rest of Middle East & Africa)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall hematology diagnostics market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report 

  • What are the current market trends and dynamics in the hematology diagnostics market and valuable opportunities for emerging players?
  • How laboratory automation has affected the dynamics of hematology diagnostics market?
  • What is the impact of fully automated analyzers along with its consumption in the developed markets?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • What is the impact of target diseases and other infectious diseases on the hematology diagnostics market?
  • What are the market trends and dynamics in emerging markets such as India, Mexico, China, South Africa, Brazil, and Gulf nations?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global HD Market Portraiture
2.2. Global HD Market, by Product Type, 2017 (US$ Mn)
2.3. Global HD Market, by End User, 2017 (US$ Mn)
2.4. Global HD Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hematology Diagnostics (HD) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. HD Technologies: Future Trends
3.3. Current Scenario: Partnerships, Mergers & New Product Launches
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2017
3.8. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Hematology Diagnostics (HD) Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Hematology Instrumentss
4.2.1. Hematology Analyzers
4.2.2. Flow Cytometers
4.2.3. Others
4.3. Hematology Consumables
4.3.1. Reagents
4.3.2. Stains
4.3.3. Controls & Calibrators
4.3.4. Others

Chapter 5. Global Hematology Diagnostics (HD) Market, by End User, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Diagnostic Laboratories
5.3. Hospitals & Clinics
5.4. Academic and Research Institutes

Chapter 6. Global Hematology Diagnostics (HD) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America HD Market Analysis, 2016 – 2026
6.2.1. North America HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.2.2. North America HD Market, by End User, 2016 – 2026 (US$ Mn)
6.2.3. North America HD Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe HD Market Analysis, 2016 – 2026
6.3.1. Europe HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe HD Market, by End User, 2016 – 2026 (US$ Mn)
6.3.3. Europe HD Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific HD Market Analysis, 2016 – 2026
6.4.1. Asia Pacific HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific HD Market, by End User, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific HD Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America HD Market Analysis, 2016 – 2026
6.5.1. Latin America HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America HD Market, by End User, 2016 – 2026 (US$ Mn)
6.5.3. Latin America HD Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) HD Market Analysis, 2016 – 2026
6.6.1. MEA HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA HD Market, by End User, 2016 – 2026 (US$ Mn)
6.6.3. MEA HD Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bio-Rad Laboratories, Inc.
7.3. Siemens Healthineers
7.4. Mindray Medical International Limited
7.5. F. Hoffmann-La Roche Ltd.
7.6. Danaher Corporation
7.7. Nihon Kohden Corporation
7.8. Drew Scientific
7.9. Sysmex Corporation
7.10. EKF Diagnostics
7.11. Boule Diagnostics
7.12. HORIBA
7.13. Diatron MI Zrt.

* HD - Hematology Diagnostics

FIG. 1 Global Hematology Diagnostics (HD) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global HD Market Segmentation
FIG. 4 Global HD Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global HD Market, by End User, 2017 (US$ Mn)
FIG. 6 Global HD Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key HD Manufacturers, 2017
FIG. 9 Global Hematology Instruments Market for Hematology Analyzers, 2016–2026 (US$ Mn)
FIG. 10 Global Hematology Instruments Market for Flow Cytometers, 2016–2026 (US$ Mn)
FIG. 11 Global Hematology Instruments Market for Others, 2016–2026 (US$ Mn)
FIG. 12 Global Hematology Consumables Market for Reagents, 2016–2026 (US$ Mn)
FIG. 13 Global Hematology Consumables Market for Stains, 2016–2026 (US$ Mn)
FIG. 14 Global Hematology Consumables Market for Controls and Calibrators, 2016–2026 (US$ Mn)
FIG. 15 Global Hematology Consumables Market for Others, 2016–2026 (US$ Mn)
FIG. 16 Global HD in Diagnostic Laboratories, 2016–2026 (US$ Mn)
FIG. 17 Global HD in Hospitals and Clinics, 2016–2026 (US$ Mn)
FIG. 18 Global HD in Academic and Research Institutes, 2016–2026 (US$ Mn)
FIG. 19 U.S. HD Market, 2016–2026 (US$ Mn)
FIG. 20 Canada HD Market, 2016–2026 (US$ Mn)
FIG. 21 U.K. HD Market, 2016–2026 (US$ Mn)
FIG. 22 Germany HD Market, 2016–2026 (US$ Mn)
FIG. 23 Rest of Europe HD Market, 2016–2026 (US$ Mn)
FIG. 24 Japan HD Market, 2016–2026 (US$ Mn)
FIG. 25 China HD Market, 2016–2026 (US$ Mn)
FIG. 26 Rest of Asia Pacific HD Market, 2016–2026 (US$ Mn)
FIG. 27 Brazil HD Market, 2016–2026 (US$ Mn)
FIG. 28 Mexico HD Market, 2016–2026 (US$ Mn)
FIG. 29 Rest of Latin America HD Market, 2016–2026 (US$ Mn)
FIG. 30 GCC HD Market, 2016–2026 (US$ Mn)
FIG. 31 Rest of Middle East & Africa HD Market, 2016–2026 (US$ Mn)

TABLE 1 Market Snapshot: Global Hematology Diagnostics (HD) Market
TABLE 2 Global HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 3 Global HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 4 Global HD Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 6 North America HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 7 North America HD Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 9 Europe HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 10 Europe HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 12 Asia Pacific HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 Asia Pacific HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Latin America HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 15 Latin America HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 16 Latin America HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa HD Market, by Region, 2016–2026 (US$ Mn)
TABLE 20 Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Bio-Rad Laboratories, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Siemens Healthineers: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Mindray Medical International Limited.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Nihon Kohden Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Drew Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Sysmex Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 EKF Diagnostics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Boule Diagnostics.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 HORIBA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Diatron MI Zrt.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients